Soleno Therapeutics stockholders approve all six proposals at 2023 annual meeting

SOLENO THERAPEUTICS INC

Elected Ernest Mario and Birgitte Volck as Class II directors with ~64.8% and ~66.7% of votes cast, respectively.
Ratified Marcum LLP as independent auditor for fiscal 2023 (5,977,682 for, 113,718 against).
Advisory say-on-pay approved (4,019,358 for, 111,424 against); board accepted three-year frequency.
Approved amended 2014 Equity Incentive Plan (3,874,198 for, 254,424 against).
Approved issuance of shares upon exercise of warrants from May 8, 2023 private placement (4,003,720 for, 132,021 against).

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.98

SOLENO THERAPEUTICS INC shareholders approved Approval of Named Executive Officer compensation on an advisory basis at the 2023-05-25 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-05-25

Exact text from the filing

Votes For Votes Against Abstentions Broker Non-Votes 4,019,358 111,424 15,486 1,949,693

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.98

SOLENO THERAPEUTICS INC shareholders approved Ratification of appointment of Marcum LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-05-25 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-05-25

Exact text from the filing

Votes For Votes Against Abstentions Broker Non-Votes 5,977,682 113,718 4,561 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.97

SOLENO THERAPEUTICS INC shareholders approved Approval of frequency of stockholder votes on Named Executive Officer compensation on an advisory basis at the 2023-05-25 meeting.

Proposal: say on pay frequency
Outcome: passed
Meeting: 2023-05-25

Exact text from the filing

Votes For Every 3 Years Votes for Every 2 Years Votes for Every 1 Years Abstentions Broker Non-Votes 2,234,536 18,934 1,865,518 27,280 1,949,693

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.97

SOLENO THERAPEUTICS INC shareholders approved Approval of issuance of shares upon exercise of warrants sold in private placement on May 8, 2023 at the 2023-05-25 meeting.

Outcome: passed
Meeting: 2023-05-25

Exact text from the filing

Votes For Votes Against Abstentions Broker Non-Votes 4,003,720 132,021 10,527 1,949,693

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.98

SOLENO THERAPEUTICS INC shareholders approved Approval of Amended and Restated 2014 Equity Incentive Plan at the 2023-05-25 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2023-05-25

Exact text from the filing

Votes For Votes Against Abstentions Broker Non-Votes 3,874,198 254,424 17,646 1,949,693

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

SOLENO THERAPEUTICS INC shareholders approved Election of two Class II directors at the 2023-05-25 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-05-25

Exact text from the filing

Nominee Votes For Votes Withheld Percent of Voted Broker Non-Votes Ernest Mario 3,950,528 195,740 64.8 % 1,949,693 Birgitte Volck 4,066,365 79,903 66.7 % 1,949,693

View on SEC.gov

561 shareholder votes filed in the last 30 days. Browse all shareholder votes →

SOLENO THERAPEUTICS INC filing history →

Source: SEC EDGAR

accession 0001193125-23-155448

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.